Literature DB >> 15701297

Children with hepatitis C.

Girish Subba Rao1, Jean Pappas Molleston.   

Abstract

Hepatitis C affects thousands of children throughout the world. Most children acquire the virus through vertical transmission, although parenteral routes of acquisition are also common. Hepatitis C progresses slowly, with mild biopsy findings and no symptoms in most children and in many adults. However, significant liver inflammation and fibrosis can occur in childhood. Trials of antiviral therapy with interferon and ribavirin have shown these drugs to be effective in almost half of the children treated. Children tend to tolerate therapy well. Further research on the natural history and treatment of hepatitis C in children is needed because the infection can have serious long-term consequences, including end-stage liver disease and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701297     DOI: 10.1007/s11894-005-0064-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  56 in total

Review 1.  Mother-to-infant transmission of hepatitis C virus.

Authors:  L T Yeung; S M King; E A Roberts
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

2.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

3.  An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

Authors:  Karen R Jacobson; Karen Murray; Aglaia Zellos; Kathleen B Schwarz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-01       Impact factor: 2.839

Review 4.  The epidemiology of hepatitis C virus infection.

Authors:  Tommy Yen; Emmet B Keeffe; Aijaz Ahmed
Journal:  J Clin Gastroenterol       Date:  2003-01       Impact factor: 3.062

Review 5.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

6.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

Authors:  M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

7.  Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis.

Authors:  R Iorio; P Pensati; S Botta; S Moschella; N Impagliazzo; P Vajro; A Vegnente
Journal:  Pediatr Infect Dis J       Date:  1997-10       Impact factor: 2.129

8.  Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.

Authors:  Ioannis Kyrlagkitsis; Bernard Portmann; Heather Smith; John O'Grady; Matthew E Cramp
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

9.  Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.

Authors:  M Ruiz-Moreno; M J Rua; I Castillo; M D García-Novo; M Santos; S Navas; V Carreño
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

10.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.